Oct 02, 2024
Rheumatoid arthritis is a chronic autoimmune disease that wreaks havoc on the joints, causing progressive and destructive polyarthritis. According to the World Health Organization, approximately 18 million people globally live with this condition, with about 1.5 million cases reported in the U.S. Characterized by r...
Read More...
Feb 23, 2016
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. The...
Read More...
Feb 23, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. The Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2...
Read More...
Feb 08, 2016
DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 has received great response and feedback from clients. PD-1and PDL-1 is...
Read More...
Jan 21, 2016
DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016”to its portfolio. Reports Highlights: · CAR-T cell Therapy Pipeline scenario · Collaborations &...
Read More...
Jan 13, 2016
DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio. With this launch DelveInsight now has 400+ Reports on Drug Insight. In addition to this our research expertise provides our clients with up to date information of market till date orde...
Read More...
Jan 12, 2016
DelveInsight, the leading market research and consulting company has added new report Head and Neck Squamous Cell Carcinoma -Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clien...
Read More...
Jan 12, 2016
DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date i...
Read More...
Jan 12, 2016
DelveInsight, the leading market research and consulting company has added new report Peripheral Lung Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date inf...
Read More...
Aug 01, 2025
The field of gene regulation and molecular medicine has witnessed a revolutionary advancement with the development of small interfering RNA (siRNA) therapeutics. Also known as short interfering RNA, siRNA is a class of double-stranded RNA molecules that plays a pivotal role in RNA interference (RNAi)—a cellular mec...
Read More...